AAAAAA

   
Results: 1-7 |
Results: 7
SAFETY, TOLERANCE, AND PHARMACOKINETICS OF A SMALL UNILAMELLAR LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN NEUTROPENIC PATIENTS
Authors: WALSH TJ YELDANDI V MCEVOY M GONZALEZ C CHANOCK S FREIFELD A SEIBEL NI WHITCOMB PO JAROSINSKI P BOSWELL G BEKERSKY I ALAK A BUELL D BARRET J WILSON W
Citation: Tj. Walsh et al., SAFETY, TOLERANCE, AND PHARMACOKINETICS OF A SMALL UNILAMELLAR LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN NEUTROPENIC PATIENTS, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2391-2398
USE OF FLUOROQUINOLONES FOR EMPIRICAL MANAGEMENT OF FEBRILE NEUTROPENIA IN PEDIATRIC CANCER-PATIENTS
Authors: FREIFELD A PIZZO P
Citation: A. Freifeld et P. Pizzo, USE OF FLUOROQUINOLONES FOR EMPIRICAL MANAGEMENT OF FEBRILE NEUTROPENIA IN PEDIATRIC CANCER-PATIENTS, The Pediatric infectious disease journal, 16(1), 1997, pp. 140-146
CIPROFLOXACIN QUINOLONE USE IN NON-CYSTIC FIBROSIS PATIENTS - PANEL DISCUSSION/
Authors: SCHAAD U REDMOND A GREEN S KOYLE M PATRICK C FREIFELD A YOGEV R ECHOLS R KUHN R SUDHAKAR R CHURCH D
Citation: U. Schaad et al., CIPROFLOXACIN QUINOLONE USE IN NON-CYSTIC FIBROSIS PATIENTS - PANEL DISCUSSION/, The Pediatric infectious disease journal, 16(1), 1997, pp. 160-162
RAPID IDENTIFICATION OF RESPIRATORY VIRUSES - IMPACT ON ISOLATION PRACTICES AND TRANSMISSION AMONG IMMUNOCOMPROMISED PEDIATRIC-PATIENTS
Authors: BEEKMANN SE ENGLER HD COLLINS AS CANOSA J HENDERSON DK FREIFELD A
Citation: Se. Beekmann et al., RAPID IDENTIFICATION OF RESPIRATORY VIRUSES - IMPACT ON ISOLATION PRACTICES AND TRANSMISSION AMONG IMMUNOCOMPROMISED PEDIATRIC-PATIENTS, Infection control and hospital epidemiology, 17(9), 1996, pp. 581-586
EARLY EMPIRIC ANTIBIOTIC-THERAPY FOR FEBRILE NEUTROPENIA PATIENTS AT LOW-RISK
Authors: ROLSTON KVI RUBENSTEIN EB FREIFELD A
Citation: Kvi. Rolston et al., EARLY EMPIRIC ANTIBIOTIC-THERAPY FOR FEBRILE NEUTROPENIA PATIENTS AT LOW-RISK, Infectious disease clinics of North America, 10(2), 1996, pp. 223
COLONY-STIMULATING FACTORS AND NEUTROPENIA - INTERSECTION OF DATA ANDCLINICAL RELEVANCE COLONY-STIMULATING FACTORS AND NEUTROPENIA - INTERSECTION OF DATA AND CLINICAL RELEVANCE
Authors: FREIFELD A PIZZO P
Citation: A. Freifeld et P. Pizzo, COLONY-STIMULATING FACTORS AND NEUTROPENIA - INTERSECTION OF DATA ANDCLINICAL RELEVANCE COLONY-STIMULATING FACTORS AND NEUTROPENIA - INTERSECTION OF DATA AND CLINICAL RELEVANCE, Journal of the National Cancer Institute, 87(11), 1995, pp. 781-782
GUIDELINES FOR THE PREVENTION AND TREATMENT OF B-VIRUS INFECTIONS IN EXPOSED PERSONS
Authors: HOLMES GP CHAPMAN LE STEWART JA STRAUS SE HILLIARD JK DAVENPORT DS ADAMS SR ANDERSON DC BALK M BRODERSON JR BROWN B BROWN D BROWN NA DILLEHAY D ELSE J FREEMAN D FREIFELD A HEBERLING RL HERRMANN K HILLIARD J HOLMES G HUERKAMP M JAAX J JOHNSON D KALTER SS KAUFMAN A LAUGHLIN C LEHNER N LISELLA FS LOPEZ CE LOPEZ C MAHY B MCCLURE HM MCKINNEY RW MCVICAR J MONATH T MULLIGAN D MURPHY F NAHMIAS AJ OXMAN MN PELLETT PE RICHARDSON JH SILBERMAN MS SOIKE K SOUTHERS JL WARREN M WELLS D WHITLEY R
Citation: Gp. Holmes et al., GUIDELINES FOR THE PREVENTION AND TREATMENT OF B-VIRUS INFECTIONS IN EXPOSED PERSONS, Clinical infectious diseases, 20(2), 1995, pp. 421-439
Risultati: 1-7 |